Watch: The Extraordinary Impact of Clinical Trial Research for Rare Neurogenetic Diseases

tags: Batten Disease Clinic Clinical Trials Unit at Kennedy Krieger Institute Latest News Research

Join Dr. Bradley L. Schlaggar, president and CEO of Kennedy Krieger Institute, and Dr. Erika Augustine, associate chief science officer for Kennedy Krieger and director of the Institute’s Clinical Trials Unit, as they discuss exciting, key advances in therapy for rare diseases of the pediatric nervous system—advances that have been made possible by clinical trials research. They also share what’s on the horizon for the millions of individuals impacted by rare diseases and disorders of the developing nervous system.

Subscribe to receive advance notice of Exploring the Brain webinars.
Subscribe Today